Mitzy Stewart, APRN
Psychiatric/Mental Health · Layton, UTNPI 1538147418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 33.1% of the total. Reporting peaked in 2023 at $1,384 and has fallen 93.6% since, to $89 in 2024.
Across 105 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$901
- Otsuka America Pharmaceutical, Inc.$504
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$364
- Alkermes, Inc.$214
- Sunovion Pharmaceuticals Inc.$152
- Neurocrine Biosciences, Inc.$126
- plus $458 from 6 others
What the payments were for
- Food & beverage$2,718100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 22 | $901 |
| Otsuka America Pharmaceutical, Inc. | 30 | $504 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $364 |
| Alkermes, Inc. | 9 | $214 |
| Sunovion Pharmaceuticals Inc. | 10 | $152 |
| Neurocrine Biosciences, Inc. | 4 | $126 |
| AbbVie | 5 | $118 |
| Idorsia Pharmaceuticals US Inc | 4 | $108 |
| Vanda Pharmaceuticals Inc. | 6 | $106 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$270
- CAPLYTA$125
- SPRAVATO$108
How this compares
$2,718 in reported general payments places this provider in the 85th percentile of 393 psychiatric/mental health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 11 | $5,063 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 44 | $1,548 |
| Atomoxetine Hcl | 17 | $1,503 |
| Quetiapine Fumarate | 25 | $399 |
| Lamotrigine | 29 | $364 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $354 |
| Prazosin Hcl | 12 | $347 |
| Escitalopram Oxalate | 30 | $339 |
| Ziprasidone Hcl | 13 | $275 |
| Buspirone Hcl | 17 | $210 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $205 |
| Lorazepam | 43 | $130 |
| Trazodone Hcl | 27 | $119 |
| Clonazepam | 16 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Layton
- Bret HafenLayton$381K
- Colby JamesLayton$8K
- Craig FrancisLayton$7K
- Benjamin SaxeyLayton$7K
- Heather KrambuleLayton$6K
- Sherrie SmithLayton$4K
- Marie HurstLayton$4K
- Colin RileyLayton$3K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.